ANZTCT Australia New Zealand Transplant & Cellular Therapies About ANZTCT Australia and New Zealand Transplant and Cellular Therapies Ltd (ANZTCT), formerly known as the Bone Marrow Transplant Society of Australia and New Zealand, is a society consisting of clinicians, advanced trainees, scientists, medical graduates, nurses and pharmacists, involved in the clinical or laboratory management of patients undergoing blood or marrow stem cell transplantation or with an interest in the field of blood or marrow stem cell transplantation and cellular therapies research. Participate Participate in the development of locally relevant consensus practice guidelines Access Gain access to a network of local BMT physicians and trainees Opportunities Get opportunities for research, advocacy and development of the field COVID-19 Updates & Resources The ANZTCT has created a dedicated page to provide regular updates, useful information, and resources on the novel coronavirus disease (COVID-19) for TCT Clinicians, Specialists, Nurses, and their patients and carers across Australia and New Zealand. Upcoming Events EBMT-EHA 5th European CAR T-cell Meeting EBMT 49TH Annual Meeting ASTCT + EBMT Joint Basic and Translation Scientific Meeting Blood 2023 News & Updates Mar 29 ANZTCT Position Statement: COVID-19 Management in Haematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T cell Patients 29 March 2022 / 2 mins read Read More Jan 20 ANZTCT COVID-19 Vaccination Position Statement / 10 mins read Read More Apr 15 Australia and New Zealand Transplant and Cellular Therapies COVID19 Consensus Position Statement 15th April 2020 / 4 mins read Read More Mar 15 Bulletin #2: Practical suggestions for BMT programmes dealing with COVID-19 / 1 min read Read More ANZTCT is a registered charity with the Australian Charities and Non-for-profits Commission. Australia and New Zealand Transplant and Cellular Therapies Limited Level 6, 370 Victoria St, Kinghorn Cancer Centre, Darlinghurst NSW 2010 ACN: 642 523 171 | ABN: 58 930 578 025
Mar 29 ANZTCT Position Statement: COVID-19 Management in Haematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T cell Patients 29 March 2022 / 2 mins read Read More
Apr 15 Australia and New Zealand Transplant and Cellular Therapies COVID19 Consensus Position Statement 15th April 2020 / 4 mins read Read More
Mar 15 Bulletin #2: Practical suggestions for BMT programmes dealing with COVID-19 / 1 min read Read More